Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.23
+0.01 (0.19%)
At close: Nov 20, 2024, 4:00 PM
5.31
+0.08 (1.53%)
Pre-market: Nov 21, 2024, 4:04 AM EST
Amylyx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -259.47 | 49.27 | -198.38 | -87.93 | -42.28 | -13.36 |
| Depreciation & Amortization | 1.05 | 1.09 | 0.49 | 0.05 | 0 | - |
| Loss (Gain) From Sale of Investments | -10.64 | -9.94 | -2.06 | 0.12 | - | - |
| Stock-Based Compensation | 35.83 | 37.16 | 21.71 | 3.14 | 0.24 | 0.11 |
| Other Operating Activities | 155.71 | - | - | 5.23 | 2.74 | -0.94 |
| Change in Accounts Receivable | 27.62 | -24.74 | -15.31 | - | - | - |
| Change in Inventory | -35.73 | -73.13 | -9.77 | - | - | - |
| Change in Accounts Payable | -4.75 | 15.88 | 1.85 | 0.67 | 1.42 | 1.28 |
| Change in Other Net Operating Assets | -4.71 | 16.33 | 21.58 | 3.93 | 1.18 | 2.22 |
| Operating Cash Flow | -95.09 | 11.92 | -179.87 | -74.8 | -36.7 | -10.69 |
| Capital Expenditures | -36.7 | -1.24 | -2.53 | -0.35 | -0.15 | - |
| Investment in Securities | 68.3 | 93.29 | -236.46 | -46.05 | - | - |
| Investing Cash Flow | 31.6 | 92.05 | -238.99 | -46.41 | -0.15 | - |
| Long-Term Debt Issued | - | - | - | 26.16 | 16.82 | 0.64 |
| Long-Term Debt Repaid | - | - | - | -0.26 | - | - |
| Net Debt Issued (Repaid) | - | - | - | 25.9 | 16.82 | 0.64 |
| Issuance of Common Stock | 2.33 | 6.99 | 434.64 | 0.34 | 0.05 | 0.03 |
| Repurchase of Common Stock | -1.86 | -3.32 | - | - | - | - |
| Other Financing Activities | - | -0.14 | -2.85 | -2.73 | - | - |
| Financing Cash Flow | 0.47 | 3.54 | 431.79 | 158.51 | 46.82 | 0.67 |
| Foreign Exchange Rate Adjustments | 0.32 | 0.16 | -0.07 | 0.01 | - | - |
| Net Cash Flow | -62.7 | 107.68 | 12.87 | 37.31 | 9.98 | -10.02 |
| Free Cash Flow | -131.78 | 10.68 | -182.4 | -75.15 | -36.85 | -10.69 |
| Free Cash Flow Margin | -67.07% | 2.80% | -820.50% | -26369.12% | -5668.92% | -749.44% |
| Free Cash Flow Per Share | -1.94 | 0.15 | -3.12 | -11.41 | -6.06 | -1.81 |
| Cash Income Tax Paid | 1.68 | 6.39 | 0.03 | - | - | - |
| Levered Free Cash Flow | -78.9 | 38.36 | -105.35 | -46.85 | -23.54 | - |
| Unlevered Free Cash Flow | -78.9 | 38.36 | -105.35 | -46.85 | -22.11 | - |
| Change in Net Working Capital | -76.72 | 22.9 | -0.82 | -2 | -2.17 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.